The Prague Post - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.194361
AFN 73.094059
ALL 93.80832
AMD 420.063732
ANG 2.044819
AOA 1047.874554
ARS 1699.725634
AUD 1.647565
AWG 2.058635
AZN 1.938866
BAM 1.952799
BBD 2.302023
BDT 140.923459
BGN 1.931155
BHD 0.430957
BIF 3399.724876
BMD 1.1421
BND 1.474998
BOB 7.915184
BRL 5.905686
BSD 1.142974
BTN 108.888068
BWP 15.415717
BYN 3.316249
BYR 22385.161332
BZD 2.298728
CAD 1.62502
CDF 2565.156425
CHF 0.919956
CLF 0.026739
CLP 1052.37716
CNY 7.753835
CNH 7.760222
COP 3822.083561
CRC 520.722663
CUC 1.1421
CUP 30.265652
CVE 110.098235
CZK 24.162554
DJF 203.532601
DKK 7.474862
DOP 67.708924
DZD 152.145329
EGP 56.088654
ERN 17.131501
ETB 183.282196
FJD 2.55916
FKP 0.855378
GBP 0.856329
GEL 3.009446
GGP 0.855378
GHS 12.984049
GIP 0.855378
GMD 82.82724
GNF 10024.036075
GTQ 8.722788
GYD 239.083096
HKD 8.957063
HNL 30.592332
HRK 7.536145
HTG 149.49683
HUF 353.210477
IDR 20558.943323
ILS 3.434352
IMP 0.855378
INR 108.953377
IQD 1497.264876
IRR 1571472.588244
ISK 143.996042
JEP 0.855378
JMD 180.948593
JOD 0.809745
JPY 185.306306
KES 147.686675
KGS 99.874025
KHR 4577.187193
KMF 492.245363
KPW 1027.890461
KRW 1751.233471
KWD 0.354599
KYD 0.952578
KZT 540.523105
LAK 25808.585816
LBP 102352.807276
LKR 382.838497
LRD 207.440342
LSL 18.539405
LTL 3.372324
LVL 0.690845
LYD 7.325936
MAD 10.688744
MDL 20.104987
MGA 4845.68149
MKD 61.639861
MMK 2398.12993
MNT 4091.42228
MOP 9.233217
MRU 45.615904
MUR 53.75908
MVR 17.657117
MWK 1982.006544
MXN 19.960426
MYR 4.660457
MZN 72.991275
NAD 18.539324
NGN 1564.859826
NIO 42.057217
NOK 11.244375
NPR 174.224916
NZD 2.009942
OMR 0.439144
PAB 1.142994
PEN 3.889124
PGK 5.021504
PHP 70.270033
PKR 317.768369
PLN 4.289505
PYG 6949.504053
QAR 4.178171
RON 5.230364
RSD 117.371385
RUB 88.967237
RWF 1673.382552
SAR 4.292654
SBD 9.20366
SCR 16.633676
SDG 685.824136
SEK 11.042451
SGD 1.477266
SHP 0.852693
SLE 27.810602
SLL 23949.27156
SOS 653.256275
SRD 42.904157
STD 23639.165516
STN 24.463481
SVC 10.00107
SYP 126.238716
SZL 18.536005
THB 38.065954
TJS 10.594774
TMT 4.008771
TND 3.37329
TOP 2.749903
TRY 53.475415
TTD 7.746334
TWD 36.592545
TZS 3000.865602
UAH 50.904119
UGX 4171.77236
USD 1.1421
UYU 45.969163
UZS 13692.02101
VES 729.691469
VND 30037.802837
VUV 135.903032
WST 3.167257
XAF 655.01074
XAG 0.018393
XAU 0.000275
XCD 3.086582
XCG 2.059925
XDR 0.81457
XOF 654.967792
XPF 119.331742
YER 270.734961
ZAR 18.533829
ZMK 10280.270904
ZMW 21.001281
ZWL 367.755756
  • CMSC

    0.0400

    21.99

    +0.18%

  • RBGPF

    2.5400

    68.15

    +3.73%

  • BP

    1.2500

    37.4

    +3.34%

  • BTI

    1.2100

    61.77

    +1.96%

  • RYCEF

    0.5400

    19.68

    +2.74%

  • NGG

    2.6700

    82.85

    +3.22%

  • RIO

    1.0700

    94.42

    +1.13%

  • GSK

    2.3600

    53.66

    +4.4%

  • RELX

    0.5500

    31.93

    +1.72%

  • BCE

    0.4000

    21.42

    +1.87%

  • VOD

    0.1400

    13.15

    +1.06%

  • CMSD

    -0.0300

    22.15

    -0.14%

  • JRI

    0.0600

    13

    +0.46%

  • BCC

    0.4500

    75.93

    +0.59%

  • AZN

    11.2900

    195.15

    +5.79%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

J.Simacek--TPP